Opioid Use Disorder

The AHA Dec. 7 sent a letter supporting the Support for Patients and Communities Reauthorization Act (H.R. 4531), bipartisan legislation that would reauthorize key SUPPORT Act programs for patients with substance use disorder and permanently extend required Medicaid coverage for medication-assisted…
The Centers for Disease Control and Prevention recently awarded $279 million to help state and local health departments respond to the drug overdose crisis through treatment and surveillance.
Pregnant people with opioid use disorder are more likely to receive buprenorphine (a recommended treatment) if they are older, white and have public insurance.
AHA developed a suite of opioid stewardship strategies, guides and other resources to help hospitals and health systems address the growing epidemic.
For people struggling with opioid use disorder, the COVID-19 pandemic has become a crisis on top of a crisis. These tools and resources were developed to help your hospital or health system build or advance opioid stewardship during this critical time and beyond.
Mobilize community partnerships to develop and implement prevention, intervention, and treatment activities for opioid use and misuse. These resources can help.
You can develop a successful opioid stewardship practice. Use these resources to help recognize, prevent and treat opioid misuse and save lives.
The nation is facing an unprecedented opioid crisis. AHA developed a full suite of opioid stewardship strategies, insights, guides and other resources to help your hospital or health system address this growing epidemic and save lives.
New results from an ongoing clinical trial provide strong evidence that emergency departments can safely start buprenorphine treatment for opioid use disorder without triggering withdrawal in people who use fentanyl, the National Institutes of Health reports.
Medicare patients who have access to telehealth services and medications for opioid use disorder have lower risk of fatal drug overdose, according to a study reported yesterday in JAMA Psychiatry.